Custom Dulaglutide CAS 923950-08-7 - Leading China Suppliers and Reliable Factory for High-Quality Production Manufacturers, Quotes
Product Description
Deslorelin is a synthetic gonadotropin-releasing hormone (GnRH) analog with a potency approximately 30–150 times that of natural GnRH. As a GnRH agonist, it initially and briefly stimulates the pituitary gland to release gonadotropins (the "flare-up" effect). Subsequently, through sustained agonistic action, it leads to pituitary desensitization and downregulation of GnRH receptors, thereby inhibiting the secretion of gonadotropins (LH, FSH) and ultimately suppressing the production of sex steroid hormones.
Mechanism & Efficacy
Dulaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the action of endogenous GLP-1, stimulating glucose-dependent insulin secretion, suppressing glucagon release, delaying gastric emptying, and promoting satiety. These effects collectively contribute to improved glycemic control, reduced postprandial glucose levels, and weight management support in research models.
Dosage & Research Use
For research purposes, dulaglutide dosing is typically based on model specification (in vitro or in vivo) and experimental design. In preclinical rodent studies, doses often range from 0.1 mg/kg to 1 mg/kg administered subcutaneously once weekly. For larger animal models, dose adjustments are made according to body weight and pharmacodynamic response. Dulaglutide’s extended half-life supports once-weekly dosing in both preclinical and translational studies. Researchers should follow institutional guidelines and safety protocols when handling and dosing.
What is Deslorelin?
Deslorelin is a synthetic gonadotropin-releasing hormone (GnRH) analog with a potency approximately 30–150 times greater than that of natural GnRH.
How does Deslorelin affect the pituitary gland?
As a GnRH agonist, it initially stimulates the pituitary gland to release gonadotropins (the "flare-up" effect). With sustained action, it leads to pituitary desensitization and downregulation of GnRH receptors, ultimately inhibiting gonadotropin secretion.
What is Dulaglutide and how does it work?
Dulaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics endogenous GLP-1 to stimulate glucose-dependent insulin secretion, suppress glucagon release, delay gastric emptying, and promote satiety.
What are the primary benefits of Dulaglutide in research models?
Its effects collectively contribute to improved glycemic control, reduced postprandial glucose levels, and support for weight management in various research models.
What is the typical dosage of Dulaglutide in preclinical rodent studies?
In preclinical rodent studies, Dulaglutide doses typically range from 0.1 mg/kg to 1 mg/kg, administered subcutaneously once a week.
Why is Dulaglutide administered on a once-weekly basis?
Dulaglutide features an extended half-life, which effectively supports a convenient once-weekly dosing schedule in both preclinical and translational studies.
